---
title: "Natco Pharma Ltd (NATCOPHARM) — Share Price, Financials & Analysis"
symbol: "NATCOPHARM"
company: "Natco Pharma Ltd"
canonical: "https://tapetide.com/stocks/NATCOPHARM"
isin: "INE987B01026"
nse_symbol: "NATCOPHARM"
bse_code: "524816"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 14498.94
generated_at: "2026-09-13T19:22:22.583Z"
---

# Natco Pharma Ltd (NATCOPHARM)

Canonical page: https://tapetide.com/stocks/NATCOPHARM

## Company

- **NSE Symbol:** NATCOPHARM
- **BSE Code:** 524816
- **ISIN:** INE987B01026
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1995-12-27
- **CEO:** Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS.
- **Employees:** 4199
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** natcopharma.co.in

## About

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. [1]
NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]

## Latest Price

- **Price:** ₹815.35
- **Change:** -3.3 (-0.4%)
- **Open:** ₹816.1
- **Day High:** ₹821.45
- **Day Low:** ₹801.4
- **Previous Close:** ₹818.65
- **Volume:** 567956
- **As Of:** 2026-09-11T10:29:35+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:29.525788Z.

- **Market Cap:** ₹14498.94 Cr
- **Classification:** Microcap
- **P/E (reported):** 12.8
- **P/E (TTM):** 12.76
- **EPS (TTM):** ₹63.89
- **EPS (reported):** ₹91.37
- **Book Value:** ₹514.83
- **Price to Book:** 1.59
- **Dividend Yield:** 0.18%
- **ROE:** 14.88%
- **ROCE:** 16.26%
- **Debt to Equity:** 0.08
- **Revenue (yearly):** ₹4375.9 Cr
- **Net Income:** ₹1371.9 Cr
- **EBITDA:** ₹1734.1 Cr
- **52-Week High:** ₹1226.8
- **52-Week Low:** ₹789
- **RSI (14):** 29.52

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 65.12 | 9% |
| growth | 2.2 | 9% |
| momentum | 18.54 | 12% |
| ownership | 45.6 | 24% |
| quality | 60.98 | 22% |
| valuation | 79.32 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 28.1% CAGR over last 5 years

### Weaknesses

- Tax rate seems low

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 4.21% | 45.95% | — |
| ebitda margin growth | 19.62% | -25.66% | -12.98% | 123.39% |
| net income growth | -23.23% | -27.16% | 27% | 28% |
| revenue growth | -2.75% | -8.53% | 15% | 15% |
| roce | 28.13% | -46.02% | -43.01% | 19.51% |
| roe | -23.23% | -39.85% | 21.11% | 272.93% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1031 | 759 | 1068 | 1363 | 1371 | 475 | 1221 | 1329 | 1363 | 647 | 739 | 735 |
| Expenses | 573 | 490 | 571 | 558 | 567 | 436 | 673 | 758 | 784 | 489 | 612 | 549 |
| Operating Profit | 458 | 268 | 497 | 805 | 804 | 39 | 548 | 571 | 579 | 159 | 128 | 186 |
| OPM % | 44 | 35 | 47 | 59 | 59 | 8 | 45 | 43 | 42 | 25 | 17 | 25 |
| Other Income | 29 | 37 | 42 | 48 | 64 | 176 | 66 | 62 | 100 | 58 | 78 | 59 |
| Interest | 4 | 5 | 6 | 5 | 4 | 4 | 10 | 3 | 13 | 10 | 11 | 13 |
| Depreciation | 44 | 44 | 56 | 44 | 46 | 47 | 98 | 58 | 52 | 46 | 50 | 47 |
| Profit before tax | 440 | 256 | 478 | 804 | 818 | 164 | 506 | 572 | 614 | 161 | 144 | 186 |
| Tax % | 16 | 17 | 19 | 17 | 17 | 19 | 20 | 16 | 16 | 13 | -62 | 34 |
| Net Profit | 369 | 213 | 386 | 668 | 676 | 132 | 406 | 480 | 518 | 151 | 269 | 206 |
| EPS in Rs | 20.6 | 11.88 | 21.57 | 37.32 | 37.81 | 7.43 | 22.7 | 26.84 | 28.94 | 8.46 | 14.96 | 11.53 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2185 | 2094 | 1915 | 2052 | 1945 | 2707 | 3999 | 4430 | 4078 | 3485 |
| Expenses | 1256 | 1300 | 1332 | 1446 | 1681 | 1772 | 2245 | 2234 | 2617 | 2433 |
| Operating Profit | 928 | 795 | 583 | 606 | 264 | 936 | 1754 | 2196 | 1462 | 1052 |
| OPM % | 42 | 38 | 30 | 30 | 14 | 35 | 44 | 50 | 36 | 30 |
| Other Income | 40 | 130 | 107 | 104 | 99 | 105 | 126 | 354 | 272 | 295 |
| Interest | 15 | 19 | 22 | 13 | 18 | 14 | 19 | 24 | 37 | 46 |
| Depreciation | 66 | 81 | 100 | 117 | 143 | 164 | 187 | 235 | 207 | 196 |
| Profit before tax | 887 | 825 | 569 | 580 | 202 | 862 | 1674 | 2291 | 1491 | 1104 |
| Tax % | 22 | 22 | 19 | 24 | 16 | 17 | 17 | 18 | 8 | — |
| Net Profit | 695 | 642 | 458 | 442 | 170 | 715 | 1388 | 1883 | 1418 | 1145 |
| EPS in Rs | 37.74 | 35.24 | 25.31 | 24.18 | 9.31 | 39.18 | 77.51 | 105.26 | 79.2 | 63.89 |
| Dividend Payout % | 22 | 18 | 27 | 22 | 48 | 14 | 12 | 6 | 6 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 35 | 37 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
| Reserves | 1614 | 3035 | 3452 | 3737 | 4085 | 4227 | 4837 | 5817 | 7571 | 9185 |
| Borrowings | 222 | 173 | 386 | 316 | 268 | 416 | 167 | 371 | 279 | 714 |
| Other Liabilities | 446 | 470 | 428 | 498 | 403 | 430 | 617 | 682 | 744 | 1138 |
| Total Liabilities | 2318 | 3715 | 4303 | 4588 | 4792 | 5109 | 5657 | 6906 | 8631 | 11074 |
| Fixed Assets | 833 | 1019 | 1227 | 1584 | 2023 | 2312 | 2427 | 2491 | 2698 | 2803 |
| CWIP | 336 | 480 | 638 | 518 | 223 | 130 | 64 | 137 | 225 | 294 |
| Investments | 32 | 76 | 169 | 112 | 304 | 308 | 392 | 539 | 474 | 3127 |
| Other Assets | 1116 | 2140 | 2270 | 2373 | 2242 | 2360 | 2774 | 3739 | 5234 | 4850 |
| Total Assets | 2318 | 3715 | 4303 | 4588 | 4792 | 5109 | 5657 | 6906 | 8631 | 11074 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 346 | 464 | 669 | 417 | 299 | 46 | 849 | 1212 | 1697 | 1768 |
| Cash from Investing Activity | -299 | -1116 | -611 | -175 | -107 | 4 | -465 | -1026 | -1436 | -1987 |
| Cash from Financing Activity | -48 | 651 | -51 | -251 | -186 | 35 | -363 | -247 | -211 | 298 |
| Net Cash Flow | -1 | -2 | 7 | -8 | 6 | 85 | 21 | -62 | 50 | 79 |
| Free Cash Flow | 66 | 57 | 225 | 81 | 92 | -142 | 674 | 855 | 1300 | 1379 |
| CFO/OP | 69 | 72 | 107 | 90 | 71 | 36 | 110 | 85 | 94 | 148 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 86 | 106 | 88 | 105 | 73 | 116 | 115 | 109 | 103 | 79 |
| Inventory Days | 213 | 389 | 545 | 534 | 570 | 496 | 432 | 357 | 405 | 480 |
| Days Payable | 160 | 239 | 224 | 244 | 104 | 105 | 153 | 120 | 145 | 216 |
| Cash Conversion Cycle | 138 | 257 | 410 | 395 | 539 | 507 | 394 | 345 | 362 | 343 |
| Working Capital Days | 71 | 215 | 207 | 295 | 246 | 256 | 198 | 151 | 151 | 111 |
| ROCE % | 39 | 35 | 23 | 14 | 13 | 4 | 18 | 30 | 33 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 49.71% | 49.71% | 49.71% | 49.71% | 49.62% | 49.62% | 49.56% | 49.56% | 49.48% | 49.48% | 49.42% | 49.42% |
| FIIs | 12.82% | 13.72% | 16.14% | 17.45% | 17.51% | 17.94% | 17.49% | 15.51% | 14.09% | 15.16% | 17.37% | 16.99% |
| DIIs | 14.01% | 11.23% | 9.7% | 7.87% | 6.75% | 5.57% | 5.65% | 5.82% | 5.87% | 5.39% | 5.46% | 5.62% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 19.49% | 21.24% | 20.6% | 21.59% | 22.6% | 23.34% | 23.68% | 25.22% | 25.84% | 25.38% | 23.34% | 23.41% |
| Others | 3.97% | 4.1% | 3.85% | 3.39% | 3.52% | 3.53% | 3.61% | 3.89% | 4.72% | 4.58% | 4.41% | 4.56% |
| No. of Shareholders | 163753 | 207571 | 228467 | 251485 | 302944 | 345332 | 405222 | 429434 | 419699 | 424167 | 410970 | 403166 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 832.53 | Sell |
| EMA (10) | 833.57 | Sell |
| SMA (20) | 854.26 | Sell |
| EMA (20) | 852.49 | Sell |
| SMA (50) | 904.98 | Sell |
| EMA (50) | 891.54 | Sell |
| SMA (100) | 963.57 | Sell |
| EMA (100) | 922.76 | Sell |
| SMA (200) | 945.17 | Sell |
| EMA (200) | 932.47 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 28.72 | Buy |
| MACD (12,26,9) | -24.44 | Sell |
| Stochastic (14,3,3) | 11.41 | Buy |
| ADX (14) | 19.8 | Neutral |
| Williams %R (14) | -83.32 | Buy |
| ATR (14) | 21.66 | Neutral |
| ROC (12) | -5.57 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 35.18 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 37.5% |
| Hold | 2 | 25% |
| Sell | 3 | 37.5% |

Based on 8 analyst ratings, observed at 2026-09-11T04:53:29.562571+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96fd549d-6f8f-478c-9090-416d78683b17.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Issue of Securities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=347074da-dd40-45ea-a6ba-f8db3ac547a7.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=580712cf-a699-46d1-bf51-f16a6a106e11.pdf) |
| 2026-09-04 | [Board Meeting Intimation for Fund Raising](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=451f3f5d-186c-4b4c-bafb-6761e3c576d3.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d25dc00-4a7e-4acc-b5a8-d747c870ab2f.pdf) |
| 2026-09-04 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90324b57-8095-4841-88f5-1d3bc2cc3466.pdf) |
| 2026-09-04 | [Notice Of 43Rd Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3017798f-8975-4d4f-b6ac-badd4bfc93a6.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59377185-42d2-41e5-b9d4-00778be37338.pdf) |
| 2026-08-26 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05945942_0FEA_45CF_B0E1_30FC46A8E55C_144630.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b2d4c40-e6e9-41b8-b7e4-d251f6f9da25.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1842b22f-cb53-45cb-bcb2-0388e7070364.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02c8ef3b-6c4b-470e-83f0-69e880a97e9d.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f192f32c-197f-430f-b27f-7338ba5ee9a8.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=236bc8c2-778b-4af2-a104-b4e902651e29.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5fe60cd-6aa5-4ff4-9fd3-1e93a3014e6e.pdf) |
| 2025-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c755548f-c325-46ba-8d7a-8c2108a36a18.pdf) |
| 2025-07-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c9d7cd0-d102-42c5-89b3-f91787622f9d.pdf) |
| 2025-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aea686c3-f820-4f09-a6a6-99e3468a4042.pdf) |
| 2025-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7aee70f-0287-4ff8-8d04-253ad95cd48e.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=823a6560-df98-4753-b710-06bf7709d994.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bf1f51a-1007-47be-ba9b-ab9bfe320cf0.pdf) |
| 2026-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=230327e4-9a77-4095-b46d-b9c836cc9b96.pdf) |
| 2025-11-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac8f848f-8703-4403-9ae3-cb2d420d47da.pdf) |
| 2025-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c8d332-fc11-4299-9977-cb8dc43d0153.pdf) |
| 2025-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d43e2593-6819-4d99-b9a6-c3019c901490.pdf) |
| 2025-02-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=649d3521-2c1e-4ecd-ab9c-0b1292bb5559.pdf) |
| 2024-08-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dba08330-79f4-449b-bfa2-8f5fde18a088.pdf) |
| 2024-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99cc0f91-9fd5-4d78-b404-a4e50d143d60.pdf) |
| 2024-02-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ef9451-83a8-4657-acce-18d31611b872.pdf) |
| 2023-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bcbab47-7dc2-43c5-bf21-1a30b450a20c.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac8f848f-8703-4403-9ae3-cb2d420d47da.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfa2b366-9531-46e4-a6e5-1be622bc6b51.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfa2b366-9531-46e4-a6e5-1be622bc6b51.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69ef4068-751c-4c97-ae82-a551c697e63b.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69ef4068-751c-4c97-ae82-a551c697e63b.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=269dbb1f-c0d4-45c4-bdbf-e77835b39c5d.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/269dbb1f-c0d4-45c4-bdbf-e77835b39c5d.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f192f32c-197f-430f-b27f-7338ba5ee9a8.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f192f32c-197f-430f-b27f-7338ba5ee9a8.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92ba56ca-3913-4cf9-8a4e-8ced6baa567d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-29 | [Audited Financial Results For The Quarte And Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f423fa-d826-4e02-baf7-0985a80fc693.pdf) |
| 2026-02-12 | [Un Audited Financial Results For The Quarter Ending 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4f3defc-e429-4997-ab79-1a096fb5d689.pdf) |
| 2025-11-14 | [Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a28a0f3b-934c-4399-ab82-f394a1e15065.pdf) |
| 2025-08-12 | [Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f60029ee-facd-467a-be0e-d7087b619896.pdf) |
| 2025-02-12 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78c06fa9-fa0e-4350-8f28-6643f3a445b3.pdf) |
| 2024-11-12 | [Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43a9833-9804-4ef8-8e4d-fe9fa4ae381f.pdf) |
| 2024-08-12 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed474fc3-2de9-4482-a9fb-7ccec5a48183.pdf) |
| 2024-05-27 | [Audited Financial Results For The Quarter And Year Ended 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d20e5ade-c5bb-4e20-ad83-4110f4b838d4.pdf) |
| 2024-02-14 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4c87be9-9d52-4418-8487-470cbb155c89.pdf) |
| 2023-11-14 | [Financial Results For The Quarter And Half Year Ended 30Th September, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba38ed7d-3f18-422a-9967-8c55f14008a3.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Regulation 74(5) certificate submitted for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Regulation 74(5) certificate submitted for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/11a6f54a-677a-4528-b326-dabd7b926255.pdf) |
| 6 Mar - Investor meeting with Investec Promoter & Founder group on 9 March 2026, Mumbai, 09:00–17:00. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Investor meeting with Investec Promoter & Founder group on 9 March 2026, Mumbai, 09:00–17:00.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a31b773e-4561-4438-a789-78429ae1e74e.pdf) |
| 31 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 results declaration. | [Closure of Trading Window 31 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d55aaea-5f97-4f39-b18c-4be20f1e4fd3.pdf) |
| 3 Mar - Natco launches generic Pomalidomide in U.S.; $3.2bn market; 180-day shared exclusivity. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 3 Mar - Natco launches generic Pomalidomide in U.S.; $3.2bn market; 180-day shared exclusivity.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5ea62bc-df3a-437a-8d62-61601cd4d40f.pdf) |
| 25 Feb - NATCO Pharma informs BSE (25 Feb 2026) it disclosed all price-sensitive information; volume rise market-driven. | [Clarification On Volume Movement Of Shares 25 Feb - NATCO Pharma informs BSE (25 Feb 2026) it disclosed all price-sensitive information; volume rise market-driven.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8dee0d02-5c44-4df0-9acf-5e506bc988f2.pdf) |
| 25 Feb - Confirms CDSCO Semaglutide approval Feb 14, 2026; launch planned March 2026; Eris partnership; no material financial impact. | [Rumour verification - Regulation 30(11) 25 Feb - Confirms CDSCO Semaglutide approval Feb 14, 2026; launch planned March 2026; Eris partnership; no material financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c1ef757-0547-4dc7-af6b-164823c4135e.pdf) |
| 24 Mar - Board approved demerger of Agrochemicals to Natco Crop Health Sciences; 1:1 shares; Appointed Date Oct 1, 2026. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 24 Mar - Board approved demerger of Agrochemicals to Natco Crop Health Sciences; 1:1 shares; Appointed Date Oct 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/396683d2-509d-47ec-bc76-c6b2074b0deb.pdf) |
| 24 Mar - Board approved demerger of agrochemicals into Natco Crop Health Sciences; 1:1 shares; Appointed Date Oct 1, 2026; listing planned. | [Announcement under Regulation 30 (LODR)-Acquisition 24 Mar - Board approved demerger of agrochemicals into Natco Crop Health Sciences; 1:1 shares; Appointed Date Oct 1, 2026; listing planned.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2bca80a2-471c-48db-93a6-cc879a7e1ca1.pdf) |
| 24 Mar - Approved demerger of Agrochemicals into Natco Crop Health; 1:1 share issuance; Appointed Date 1 Oct 2026; resulting co to list. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th March, 2026 24 Mar - Approved demerger of Agrochemicals into Natco Crop Health; 1:1 share issuance; Appointed Date 1 Oct 2026; resulting co to list.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75dfd930-a84e-4a99-97d2-d5e647bc8862.pdf) |
| 20 Mar - Natco launches generic semaglutide vials March 21, 2026; MRP INR1,290 and INR1,750; pen device in April. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 20 Mar - Natco launches generic semaglutide vials March 21, 2026; MRP INR1,290 and INR1,750; pen device in April.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe9433c0-0a5a-42d5-91ee-bfcc79e59597.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec2824b7-a917-4b22-a59a-66dfc9532dd8.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228fbdd9-f03b-4420-b177-3290c1f4e784.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22635544-7f5f-4c0f-86cf-264c562cf1d7.pdf) |
| 2024-05-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c34d483-d5ab-48aa-b134-bfd6db34e28d.pdf) |
| 2024-02-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b128937d-9201-4baa-a3a6-3e8c615bd2ab.pdf) |
| 2023-11-16 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=680ba284-253e-4453-bc47-037b6d722b8a.pdf) |
| 2023-08-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7546b2b7-f17e-4ef9-9640-4dc836120f60.pdf) |
| 2023-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17fcbdab-740e-40c8-997e-2b4752b6e353.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08737473-9fef-496b-881b-746b8ab600b1.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5a992a3-1b5a-44b4-8e5b-343b600e56fc.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/76692336-a42d-46bd-aa85-16fbb9846663.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524816/75411524816.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524816/70606524816.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:22:22.583Z.